Clinical Trial Update: Neo-adjuvant Chemotherapy Combined With Stereotactic Body Radiotherapy to the Primary Tumour +/- Durvalumab, +/- Oleclumab in Luminal B Breast Cancer: [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating neoadjuvant chemotherapy and stereotactic body radiotherapy to the primary tumor with or without durvalumab and oleclumab in l…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Luminal Breast Cancer

Drugs mentioned

• Durvalumab (durvalumab)
• Oleclumab (oleclumab)

Snippet

Sponsor: Jules Bordet Institute | Conditions: Luminal B | Phase 2 | Status: ACTIVE_NOT_RECRUITING